The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Special report

First-in-human use of the OneShot™ renal denervation system from Covidien

EuroIntervention 2013;8:1090-1094. DOI: 10.4244/EIJV8I9A166

1. Mercy Angiography, Auckland, New Zealand; 2. Auckland City Hospital, Auckland, New Zealand; 3. Counties Manukau District Health Board, Manukau, New Zealand

Percutaneous transcatheter renal sympathetic denervation (RDN) is a promising treatment for refractory hypertension (HT). RDN was found in one series of clinical studies to reduce systolic blood pressure (SBP) by as much as

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience